Disease & Cancer

“On behalf of all of us at the Center for Oncology in Pediatrics Foundation as well as over 1,430 children and their families we have served at the COP Medical Center, we kindly extend our warmest hearts and extreme gratefulness to the Georges and Germaine Fusenot Charity Foundation for their very generous contributions. These funds greatly assist us in continuing to treat and save children’s lives suffering from cancer on a daily basis. Your philanthropic generosity had made an immediate impact on many children’s lives as we provide them with full medical treatment free of any charge thanks funding received from foundations such as yours. We look forward to working together with you for many years to come”.

Stephen G. Saunderson, President

“With heartfelt thanks and overwhelming gratitude, the National Cheers Foundation thanks the Fusenot Foundation for their generous contribution. We look forward to a long partnership supporting women’s health.”

Anseth Richards, Founder & President

"We are forever grateful for your support and most of all believing in our mission."

Joan Wyllie, CEO & Founder

“On behalf of everyone at Salk, we extend a heartfelt thanks to the Georges and Germaine Fusenot Charity Foundation for their support. Their generous contribution provides critical funding that allows the Institute to respond quickly whenever extraordinary opportunities arise or our scientists need resources to pursue promising new directions. By giving us unprecedented flexibility to meet the rapidly changing needs of our researchers, the Fusenot Foundation’s partnership will be instrumental in accelerating the process of scientific innovation for which the Salk Institute is renowned.”

Rebecca Newman, Vice President, External Relations

“Congratulations to the Georges and Germaine Fusenot Charity Foundation for 50 years of philanthropic impact. Your support has enabled the Moores Cancer Center at UC San Diego Health to complete groundbreaking research projects on promising treatments, like immunotherapy, and advance new therapies for patients battling melanoma. With over 6,000 patients treated at Moores Cancer Center each year, it is organizations like yours that allow for novel therapies to be moved from the laboratory bench to our patients’ bedsides faster than ever before. On behalf of the patients, physicians, nurses, researchers and administrators at Moores Cancer Center, thank you for your incredible generosity.”

David A. Brenner, MD, Vice Chancellor